ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2020

[Durvalumab after radiochemotherapy for locally advanced unresectable NSCLC-a breakthrough].

Matthias GuckenbergerPubMed ↗Publisher ↗

No numbers read from the abstract.